IP Verse

Monomethylfumarate Prodrug Compositions

Patent No. EP3253377 (titled "Monomethylfumarate Prodrug Compositions") was filed by Alkermes Pharma Ireland on Mar 10, 2015. The application was issued on May 12, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKFeb 11, 2022ELKINGTON AND FIFE
TEVA PHARMACEUTICALSFeb 11, 2022D YOUNG
ADALVOFeb 7, 2022BRAND MURRAY FULLER
SANDOZJan 20, 2022KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3253377

ALKERMES PHARMA IRELAND
Application Number
EP15760508A
Filing Date
Mar 10, 2015
Status
Granted And Under Opposition
Apr 9, 2021
Publication Date
May 12, 2021
External Links
Slate, Register , Google Patents